Department of Pharmaceuticals invites applications under PLI scheme to produce Vitamin B1
Promoting the Domestic Manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country, the Department of Pharmaceuticals (DoP) has invited application for the eligible product Vitamin B1, through the chemical synthesis route under Production of Linked Incentive (PLI) scheme.This came in response to the decision made at...
Promoting the Domestic Manufacturing of Critical Key Starting Materials (KSMs), Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country, the Department of Pharmaceuticals (DoP) has invited application for the eligible product Vitamin B1, through the chemical synthesis route under Production of Linked Incentive (PLI) scheme.
This came in response to the decision made at the Empowered Committee (EC) meeting on June 3, 2012, to seek applications for the eligible product Vitamin B1 made by the chemical synthesis process.
For more details, check out the full story on the link below:
DoP Invites Applications Under PLI Scheme To Produce Vitamin B1, Details
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd